ICVV Statement on World Hepatitis Day: Advancing Global Immunization Strategies to Eliminate Viral Hepatitis by 2030

On the occasion of World Hepatitis Day (July 28th), the 1st International Congress of Vaccine and Vaccination (ICVV) reaffirms its commitment to the global mission of eliminating viral hepatitis as a major public health threat. Despite significant pharmacological breakthroughs, viral hepatitis remains a leading cause of liver cirrhosis and hepatocellular carcinoma, claiming over 1.3 million lives annually worldwide.As a premier international forum for vaccinology, ICVV emphasizes a multi-faceted approach to achieve the WHO 2030 targets:Primary Prevention through Vaccination: Strengthening universal Hepatitis B (HBV) birth-dose coverage and catch-up programs for high-risk populations.Diagnostic & Therapeutic Synergy: Enhancing clinical access to high-sensitivity screening and direct-acting antivirals (DAAs) to bridge the gap in Hepatitis C (HCV) care.Evidence-Based Policy Making: Translating microbiological research into actionable public health interventions to reduce the global burden of liver disease.“One Life, One Liver”: The mantra of this year’s campaign reminds us that hepatitis-free clinical outcomes are within reach through science and collective action. We invite the global scientific community to join us this December at ICVV to discuss cutting-edge vaccine developments and integrated public health solutions.